Status:
RECRUITING
Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
Lead Sponsor:
Sun Yat-sen University
Conditions:
Graves Ophthalmopathy
Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.
Detailed Description
The purpose of the study is to evaluate the effectiveness and complications of modified deep lateral wall decompression and medial wall decompression, in order to develop a standardized technical appr...
Eligibility Criteria
Inclusion
- EUGOGO/NOSPECS grade was moderate-to-severe thyroid associate ophthalmopathy;
- CAS≤3 score;
- stable thyroid function for at least 6 months;
- able and willing to participate in clinical trials and ensure regular follow-up;
Exclusion
- any uncontrollable clinical problems (severe mental, neurological, cardiovascular, respiratory and other systemic diseases and malignant tumors);
- B-ultrasound or CT, MRI found other diseases causing exophthalmos (intraorbital space occupying lesion, inflammatory pseudotumor, neurofibroma, etc.);
- uveitis, glaucoma, high myopia, diabetic retinopathy and other eye diseases
- those who were considered by the researchers to be excluded
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06588764
Start Date
September 1 2024
End Date
January 1 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510000